Cargando…
Collateral activity of the CRISPR/RfxCas13d system in human cells
CRISPR/Cas13 systems are increasingly used for programmable targeting of RNAs. While Cas13 nucleases are capable of degrading both target RNAs and bystander RNAs in vitro and in bacteria, initial studies fail to detect collateral degradation of non-target RNAs in eukaryotic cells. Here we show that...
Autores principales: | Shi, Peiguo, Murphy, Michael R., Aparicio, Alexis O., Kesner, Jordan S., Fang, Zhou, Chen, Ziheng, Trehan, Aditi, Guo, Yang, Wu, Xuebing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049998/ https://www.ncbi.nlm.nih.gov/pubmed/36977923 http://dx.doi.org/10.1038/s42003-023-04708-2 |
Ejemplares similares
-
The collateral activity of RfxCas13d can induce lethality in a RfxCas13d knock-in mouse model
por: Li, Yunfei, et al.
Publicado: (2023) -
Optimized CRISPR-RfxCas13d system for RNA targeting in zebrafish embryos
por: Hernandez-Huertas, Luis, et al.
Publicado: (2021) -
A Mutated Nme1Cas9 Is a Functional Alternative RNase to Both LwaCas13a and RfxCas13d in the Yeast S. cerevisiae
por: Zhang, Yadan, et al.
Publicado: (2022) -
The Bacterial Enzyme RfxCas13d Is Less Neurotoxic Than PspCas13b and Could Be a Promising RNA Editing and Interference Tool in the Nervous System
por: Wu, Qin-Wei, et al.
Publicado: (2021) -
Negative autoregulation mitigates collateral RNase activity of repeat-targeting CRISPR-Cas13d in mammalian cells
por: Kelley, Chase P., et al.
Publicado: (2022)